Your browser doesn't support javascript.
loading
Complete Loss of EPCAM Immunoexpression Identifies EPCAM Deletion Carriers in MSH2-Negative Colorectal Neoplasia.
Cuatrecasas, Míriam; Gorostiaga, Iñigo; Riera, Cristina; Saperas, Esteban; Llort, Gemma; Costa, Irmgard; Matias-Guiu, Xavier; Carrato, Cristina; Navarro, Matilde; Pineda, Marta; Dueñas, Núria; Brunet, Joan; Marco, Vicente; Trias, Isabel; Busteros, José Ignacio; Mateu, Gemma; Balaguer, Francesc; Fernández-Figueras, María-Teresa; Esteller, Manel; Musulén, Eva.
Affiliation
  • Cuatrecasas M; Department of Pathology, Center of Biomedical Diagnosis (CDB), Hospital Clínic, 08036 Barcelona, Spain.
  • Gorostiaga I; Universitat de Barcelona (UB), 08007 Barcelona, Spain.
  • Riera C; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), 08036 Barcelona, Spain.
  • Saperas E; Department of Pathology, Hospital Universitario de Araba, 01009 Vitoria-Gasteiz, Spain.
  • Llort G; Gastroenterology Department, Hospital Universitari General de Catalunya-Grupo Quirónsalud, Sant Cugat del Valles, 08195 Barcelona, Spain.
  • Costa I; Gastroenterology Department, Hospital Universitari General de Catalunya-Grupo Quirónsalud, Sant Cugat del Valles, 08195 Barcelona, Spain.
  • Matias-Guiu X; Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, 08017 Barcelona, Spain.
  • Carrato C; Oncology Department, Parc Taulí Hospital Universitari, Sabadell, 08208 Barcelona, Spain.
  • Navarro M; Oncology Department, Consorci Sanitari de Terrassa, Terrassa, 08208 Barcelona, Spain.
  • Pineda M; Department of Pathology, Parc Taulí Hospital Universitari, Sabadell, 08208 Barcelona, Spain.
  • Dueñas N; Universitat de Barcelona (UB), 08007 Barcelona, Spain.
  • Brunet J; Department of Pathology, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Marco V; Department of Pathology, Hospital Universitari Arnau de Vilanova, 25198 Lleida, Spain.
  • Trias I; Universitat de Lleida, IRBLLEIDA, 25003 Lleida, Catalonia, Spain.
  • Busteros JI; Centro de Investigación Biomédica en Red Cancer (CIBERONC), 28029 Madrid, Spain.
  • Mateu G; Department of Pathology, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Barcelona, Spain.
  • Balaguer F; Centro de Investigación Biomédica en Red Cancer (CIBERONC), 28029 Madrid, Spain.
  • Fernández-Figueras MT; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Esteller M; Centro de Investigación Biomédica en Red Cancer (CIBERONC), 28029 Madrid, Spain.
  • Musulén E; Hereditary Cancer Program, Catalan Institute of Oncology, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), ONCOBELL Program, Hospitalet de Llobregat, 08908 Barcelona, Spain.
Cancers (Basel) ; 12(10)2020 Sep 29.
Article in En | MEDLINE | ID: mdl-33003511
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2020 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2020 Type: Article Affiliation country: Spain